Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Preaxia Health Care Payment Systems (PAXH) EPS (Weighted Average and Diluted) (2022 - 2025)

Preaxia Health Care Payment Systems' EPS (Weighted Average and Diluted) history spans 4 years, with the latest figure at -$0.04 for Q3 2025.

  • For Q3 2025, EPS (Weighted Average and Diluted) fell 16989.0% year-over-year to -$0.04; the TTM value through Aug 2025 reached -$0.04, down 708.0%, while the annual FY2025 figure was -$0.0, 92.0% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q3 2025 was -$0.04 at Preaxia Health Care Payment Systems, down from -$0.0 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at -$0.0 in Q3 2024 and bottomed at -$0.04 in Q3 2025.
  • The 4-year median for EPS (Weighted Average and Diluted) is -$0.0 (2023), against an average of -$0.0.
  • The largest YoY upside for EPS (Weighted Average and Diluted) was 92.0% in 2025 against a maximum downside of 16989.0% in 2025.
  • A 4-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.0 in 2022, then decreased by 0.04% to -$0.0 in 2023, then skyrocketed by 69.7% to -$0.0 in 2024, then tumbled by 5685.95% to -$0.04 in 2025.
  • Per Business Quant, the three most recent readings for PAXH's EPS (Weighted Average and Diluted) are -$0.04 (Q3 2025), -$0.0 (Q2 2025), and -$0.0 (Q1 2025).